Advertisement
Screener

Imunon, Inc. (IMNN) Financing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

Imunon, Inc. Financing Cash Flow

Imunon, Inc. (IMNN) reported Financing Cash Flow of $10.16 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-11

  • Imunon, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $10.16M, a 110.64% increase year-over-year.
  • Imunon, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$1.81K, a 101.72% decline year-over-year.
  • Imunon, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $7.19M.
  • Imunon, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $4.96M.
  • Imunon, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $17.09M, a 88.57% increase from fiscal 2024.
  • Imunon, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $9.06M.
  • Imunon, Inc. net cash provided by (used in) financing activities for fiscal 2023 was -$3.64M, a 154.12% decline from fiscal 2022.
  • Imunon, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $6.72M, a 87.73% decline from fiscal 2021.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 9 month as first filedNet Cash Provided by (Used in) Financing Activities 12 monthNet Cash Provided by (Used in) Financing Activities 12 month as first filed
2026-06-30$10.16M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11
$10.16M
10-Q · filed 2026-08-11
$17.35M
derived: sum of 3 quarters · filed 2026-08-11
$22.32M
derived: sum of 4 quarters · filed 2026-08-11
2026-03-31-$1.81K
10-Q · filed 2026-05-12
$7.19M
derived: sum of 2 quarters · filed 2026-05-12
$12.15M
derived: sum of 3 quarters · filed 2026-05-12
$16.98M
derived: sum of 4 quarters · filed 2026-08-11
2025-12-31$7.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$12.15M
derived: sum of 2 quarters · filed 2026-03-31
$16.98M
derived: sum of 3 quarters · filed 2026-08-11
$17.09M
10-K · filed 2026-03-31
2025-09-30$4.96M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$9.79M
derived: sum of 2 quarters · filed 2026-08-11
$9.89M
10-Q · filed 2025-11-13
$9.89M
derived: sum of 4 quarters · filed 2026-08-11
2025-06-30$4.83M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11
$4.93M
10-Q · filed 2026-08-11
$4.93M
derived: sum of 3 quarters · filed 2026-08-11
2025-03-31$105.69K
10-Q · filed 2026-05-12
$102.42K
derived: sum of 2 quarters · filed 2026-05-12
2024-12-31-$3.28K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$9.06M
10-K · filed 2026-03-31
2024-09-30$9.06M
10-Q · filed 2025-11-13
2023-12-31$30.25K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$108.51K
derived: sum of 2 quarters · filed 2025-02-27
-$6.11M
derived: sum of 3 quarters · filed 2025-02-27
-$3.64M
10-K · filed 2025-02-27
2023-09-30$78.26K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
-$6.14M
derived: sum of 2 quarters · filed 2024-11-07
-$3.67M
10-Q · filed 2024-11-07
-$3.22M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30-$6.22M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
-$3.75M
10-Q · filed 2024-08-14
-$3.30M
derived: sum of 3 quarters · filed 2024-08-14
-$3.36M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31$2.47M
10-Q · filed 2024-05-13
$2.92M
derived: sum of 2 quarters · filed 2024-05-13
$2.86M
derived: sum of 3 quarters · filed 2024-05-13
2022-12-31$447.31K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
$383.29K
derived: sum of 2 quarters · filed 2024-03-28
$6.72M
10-K · filed 2024-03-28
$6.72M
10-K · filed 2023-03-30
2022-09-30-$64.02K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
$6.28M
10-Q · filed 2023-11-14
2022-06-30$6.34M
10-Q · filed 2023-08-10
2021-12-31$1.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
-$8.32K
derived: sum of 2 quarters · filed 2023-03-30
$14.31M
derived: sum of 3 quarters · filed 2023-03-30
$54.77M
10-K · filed 2023-03-30
2021-09-30-$8.32K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
$14.31M
derived: sum of 2 quarters · filed 2022-11-14
$54.77M
10-Q · filed 2022-11-14
$57.33M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$14.32M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
$54.78M
10-Q · filed 2022-08-15
$57.34M
derived: sum of 3 quarters · filed 2022-08-15
$54.21M
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31$40.46M
10-Q · filed 2022-05-16
$43.02M
derived: sum of 2 quarters · filed 2022-05-16
$39.89M
derived: sum of 3 quarters · filed 2022-05-16
$52.65M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31$2.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
-$570.93K
derived: sum of 2 quarters · filed 2022-03-31
$12.19M
derived: sum of 3 quarters · filed 2022-03-31
$17.98M
10-K · filed 2022-03-31
2020-09-30-$3.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
$9.63M
derived: sum of 2 quarters · filed 2021-11-15
$15.42M
10-Q · filed 2021-11-15
$17.09M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30$12.76M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
$18.55M
10-Q · filed 2021-08-12
$20.22M
derived: sum of 3 quarters · filed 2021-08-12
$21.94M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$5.79M
10-Q · filed 2021-05-14
$7.46M
derived: sum of 2 quarters · filed 2021-05-14
$9.18M
derived: sum of 3 quarters · filed 2021-05-14
$11.88M
derived: sum of 4 quarters · filed 2021-05-14
2019-12-31$1.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19
$3.38M
derived: sum of 2 quarters · filed 2021-03-19
$6.09M
derived: sum of 3 quarters · filed 2021-03-19
$7.84M
10-K · filed 2021-03-19
2019-09-30$1.71M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16
$4.42M
derived: sum of 2 quarters · filed 2020-11-16
$6.18M
10-Q · filed 2020-11-16
$6.16M
10-Q · filed 2019-11-14
$5.80M
derived: sum of 4 quarters · filed 2020-11-16
2019-06-30$2.71M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14
$4.46M
10-Q · filed 2020-08-14
$4.09M
derived: sum of 3 quarters · filed 2020-08-14
$4.09M
derived: sum of 4 quarters · filed 2020-08-14
2019-03-31$1.75M
10-Q · filed 2020-05-15
$1.38M
derived: sum of 2 quarters · filed 2020-05-15
$1.38M
derived: sum of 3 quarters · filed 2020-05-15
$11.10M
derived: sum of 4 quarters · filed 2020-05-15
2018-12-31-$378.07K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25
-$378.07K
derived: sum of 2 quarters · filed 2020-03-25
$9.35M
derived: sum of 3 quarters · filed 2020-03-25
$10.58M
10-K · filed 2020-03-25
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
$9.72M
derived: sum of 2 quarters · filed 2019-11-14
$10.96M
10-Q · filed 2019-11-14
$36.68M
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30$9.72M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
$10.96M
10-Q · filed 2019-08-14
$36.68M
derived: sum of 3 quarters · filed 2019-08-14
$40.84M
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31$1.24M
10-Q · filed 2019-05-15
$26.96M
derived: sum of 2 quarters · filed 2019-05-15
$31.12M
derived: sum of 3 quarters · filed 2019-05-15
$34.37M
derived: sum of 4 quarters · filed 2019-05-15
2017-12-31$25.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
$29.88M
derived: sum of 2 quarters · filed 2019-03-29
$33.14M
derived: sum of 3 quarters · filed 2019-03-29
$36.45M
10-K · filed 2019-03-29
2017-09-30$4.16M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14
$7.42M
derived: sum of 2 quarters · filed 2018-11-14
$10.74M
10-Q · filed 2018-11-14
$11.01M
derived: sum of 4 quarters · filed 2018-11-14
2017-06-30$3.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14
$6.57M
10-Q · filed 2018-08-14
$6.85M
derived: sum of 3 quarters · filed 2018-08-14
$5.81M
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31$3.32M
10-Q · filed 2018-05-11
$3.59M
derived: sum of 2 quarters · filed 2018-05-11
$2.55M
derived: sum of 3 quarters · filed 2018-05-11
$6.98M
derived: sum of 4 quarters · filed 2018-05-11
2016-12-31$278.13K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-27
-$762.02K
derived: sum of 2 quarters · filed 2018-03-27
$3.67M
derived: sum of 3 quarters · filed 2018-03-27
$2.68M
10-K · filed 2018-03-27
2016-09-30-$1.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
$3.39M
derived: sum of 2 quarters · filed 2017-11-14
$2.40M
10-Q · filed 2017-11-14
$2.02M
derived: sum of 4 quarters · filed 2017-11-14
2016-06-30$4.43M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15
$3.44M
10-Q · filed 2016-08-15
$3.06M
derived: sum of 3 quarters · filed 2017-03-24
$2.05M
derived: sum of 4 quarters · filed 2017-03-24
2016-03-31-$988.49K
10-Q · filed 2016-05-16
-$1.37M
derived: sum of 2 quarters · filed 2017-03-24
-$2.38M
derived: sum of 3 quarters · filed 2017-03-24
$3.97M
derived: sum of 4 quarters · filed 2017-03-24
2015-12-31-$379.90K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24
-$1.39M
derived: sum of 2 quarters · filed 2017-03-24
$4.96M
derived: sum of 3 quarters · filed 2017-03-24
$4.08M
10-K · filed 2017-03-24
2015-09-30-$1.01M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
$5.34M
derived: sum of 2 quarters · filed 2016-11-10
$4.46M
10-Q · filed 2016-11-10
$4.46M
derived: sum of 4 quarters · filed 2016-11-10
2015-06-30$6.35M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15
$5.47M
10-Q · filed 2016-08-15
$5.47M
derived: sum of 3 quarters · filed 2016-08-15
$5.47M
derived: sum of 4 quarters · filed 2016-08-15
2015-03-31-$878.44K
10-Q · filed 2016-05-16
-$878.44K
derived: sum of 2 quarters · filed 2016-05-16
-$878.44K
derived: sum of 3 quarters · filed 2016-05-16
$4.09M
derived: sum of 4 quarters · filed 2016-05-16
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
$0.00
derived: sum of 2 quarters · filed 2016-03-30
$4.96M
derived: sum of 3 quarters · filed 2016-03-30
$18.78M
10-K · filed 2016-03-30
2014-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$4.96M
derived: sum of 2 quarters · filed 2015-11-05
$18.78M
10-Q · filed 2015-11-05
$19.26M
derived: sum of 4 quarters · filed 2016-03-30
2014-06-30$4.96M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
$18.78M
10-Q · filed 2015-08-10
$19.26M
derived: sum of 3 quarters · filed 2016-03-30
$18.79M
derived: sum of 4 quarters · filed 2016-03-30
2014-03-31$13.81M
10-Q · filed 2015-05-11
$14.29M
derived: sum of 2 quarters · filed 2016-03-30
$13.82M
derived: sum of 3 quarters · filed 2016-03-30
$22.42M
derived: sum of 4 quarters · filed 2016-03-30
2013-12-31$477.96K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
$7.72K
derived: sum of 2 quarters · filed 2016-03-30
$8.61M
derived: sum of 3 quarters · filed 2016-03-30
$29.39M
10-K · filed 2016-03-30
2013-09-30-$470.24K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$8.13M
derived: sum of 2 quarters · filed 2014-11-10
$28.91M
10-Q · filed 2014-11-10
$35.78M
derived: sum of 4 quarters · filed 2015-03-12
2013-06-30$8.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
$29.38M
10-Q · filed 2014-08-07
$36.25M
derived: sum of 3 quarters · filed 2015-03-12
$40.13M
derived: sum of 4 quarters · filed 2015-03-12
2013-03-31$20.78M
10-Q · filed 2014-05-08
$27.65M
derived: sum of 2 quarters · filed 2015-03-12
$31.53M
derived: sum of 3 quarters · filed 2015-03-12
$36.35M
derived: sum of 4 quarters · filed 2015-03-12
2012-12-31$6.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12
$10.75M
derived: sum of 2 quarters · filed 2015-03-12
$15.57M
derived: sum of 3 quarters · filed 2015-03-12
$15.52M
10-K · filed 2015-03-12
2012-09-30$3.88M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
$8.69M
derived: sum of 2 quarters · filed 2013-11-12
$8.65M
10-Q · filed 2013-11-12
$22.59M
derived: sum of 4 quarters · filed 2014-03-13
2012-06-30$4.82M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08
$4.77M
10-Q · filed 2013-08-08
$18.71M
derived: sum of 3 quarters · filed 2014-03-13
$42.09M
derived: sum of 4 quarters · filed 2014-03-13
2012-03-31-$46.34K
10-Q · filed 2013-05-09
$13.89M
derived: sum of 2 quarters · filed 2014-03-13
$37.27M
derived: sum of 3 quarters · filed 2014-03-13
$47.89M
derived: sum of 4 quarters · filed 2014-03-13
2011-12-31$13.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13
$37.32M
derived: sum of 2 quarters · filed 2014-03-13
$47.94M
derived: sum of 3 quarters · filed 2014-03-13
$52.84M
10-K · filed 2014-03-13
2011-09-30$23.37M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
$34.00M
derived: sum of 2 quarters · filed 2012-11-09
$38.90M
10-Q · filed 2012-11-09
$39.98M
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30$10.62M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14
$15.52M
10-Q · filed 2012-08-14
$16.60M
derived: sum of 3 quarters · filed 2013-03-18
$17.95M
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31$4.90M
10-Q · filed 2012-05-15
$5.98M
derived: sum of 2 quarters · filed 2013-03-18
$7.33M
derived: sum of 3 quarters · filed 2013-03-18
2010-12-31$1.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
$2.43M
derived: sum of 2 quarters · filed 2013-03-18
$2.38M
10-K · filed 2013-03-18
2010-09-30$1.35M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10
$1.30M
10-Q · filed 2011-11-10
2010-06-30-$52.40K
10-Q · filed 2011-08-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
SOLIGENIX, INC. (SNGX)United States$0.008B
EXICURE, INC. (XCUR)United States$0.008B-1.54
Traws Pharma, Inc. (TRAW)United States$0.009B-0.58
Alzamend Neuro, Inc. (ALZN)United States$0.009B
Ensysce Biosciences, Inc. (ENSC)United States$0.008B-0.37
InMed Pharmaceuticals Inc. (INM)$0.008B-0.65
Apimeds Pharmaceuticals US, Inc. (APUS)United States$0.008B
FibroBiologics, Inc. (FBLG)United States$0.009B-0.27
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97